CR Double-Crane, an Affiliate of China Resources Pharmaceutical, Wins Approval to Issue RMB3 Billion Corporate Bonds
I'm PortAI, I can summarize articles.
China Resources Double-Crane Pharmaceutical Co., Ltd., an affiliate of China Resources Pharmaceutical Group Ltd., has received approval from the China Securities Regulatory Commission to issue corporate bonds worth RMB3 billion. The approval is valid for 24 months, allowing the company to issue the bonds in tranches.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments